Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 500 of 506 entries
View as:

A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT02462928 Org: User:
Start: 06/25/15 End: 06/19/19 Due: 06/19/20

Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China

Phase: N/A Priority: Normal
NCT ID: NCT03908307 Org: User:
Start: 07/25/19 End: 09/26/21 Due: 09/26/22

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Phase: N/A Priority: Normal
NCT ID: NCT00168402 Org: User:
Start: 02/28/02 End: 10/31/05 Due: 10/31/06

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Phase: N/A Priority: Normal
NCT ID: NCT01189760 Org: User:
Start: 09/01/10 End: 09/01/11 Due: 09/01/12

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01241240 Org: User:
Start: 03/31/11 End: 09/30/13 Due: 09/30/14

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Phase: N/A Priority: Normal
NCT ID: NCT02248844 Org: User:
Start: 09/26/14 End: 08/14/17 Due: 08/14/18

A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT01678924 Org: User:
Start: 01/31/13 End: 09/30/15 Due: 09/30/16

Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT01042678 Org: User:
Start: 02/28/10 End: 12/31/10 Due: 12/31/11

A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT02028754 Org: User:
Start: 07/31/11 End: 05/31/13 Due: 05/31/14

Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)

Phase: N/A Priority: Normal
NCT ID: NCT03868254 Org: User:
Start: 04/05/19 End: 10/25/19 Due: 10/25/20

Safety and Tolerability of Trospium Chloride and Metformin Hydrochloride in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00986401 Org: User:
Start: 10/31/09 End: 11/30/09 Due: 11/30/10

Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)

Phase: N/A Priority: Normal
NCT ID: NCT01411696 Org: User:
Start: 07/31/11 End: 03/31/12 Due: 03/31/13

A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA

Phase: N/A Priority: Normal
NCT ID: NCT01655862 Org: User:
Start: 07/31/12 End: 02/28/17 Due: 02/28/18

An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A

Phase: N/A Priority: Normal
NCT ID: NCT01608659 Org: User:
Start: 04/01/11 End: 06/17/11 Due: 06/17/12

Dynamic Optical Coherence Tomography(D-OCT) Aging Study: A Preliminary Evaluation of Structural Differences Between Young and Aged Skin, Cellulite and Atrophic Acne Scars in Female Caucasian Subjects With Fitzpatrick Skin Types I-III Utilizing Non-invasive in Vivo D-OCT.

Phase: N/A Priority: Normal
NCT ID: NCT03767400 Org: User:
Start: 12/07/18 End: 07/30/19 Due: 07/30/20

Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation

Phase: N/A Priority: Normal
NCT ID: NCT04110145 Org: User:
Start: 10/14/19 End: 04/20/21 Due: 04/20/22

Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence

Phase: N/A Priority: Normal
NCT ID: NCT03052764 Org: User:
Start: 12/12/16 End: 12/10/18 Due: 12/10/19

Study to Assess Effectiveness and Adverse Events of JUVEDERM VOLBELLA With Lidocaine Injection in Correcting Infraorbital Hollowing in Chinese Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05088980 Org: User:
Start: 10/19/21 End: 11/29/23 Due: 11/29/24

BOTOX® in the Treatment of Crow's Feet Lines in China

Phase: N/A Priority: Normal
NCT ID: NCT02195687 Org: User:
Start: 09/30/14 End: 06/30/15 Due: 06/30/16

Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT00809848 Org: User:
Start: 02/28/09 End: 05/31/09 Due: 05/31/10

Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia

Phase: N/A Priority: Normal
NCT ID: NCT01325337 Org: User:
Start: 06/30/11 End: 09/30/12 Due: 09/30/13

Bimatoprost in the Treatment of Eyelash Hypotrichosis

Phase: N/A Priority: Normal
NCT ID: NCT01698554 Org: User:
Start: 11/30/12 End: 03/31/14 Due: 03/31/15

Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium

Phase: N/A Priority: Normal
NCT ID: NCT01109056 Org: User:
Start: 06/30/10 End: 06/30/11 Due: 06/30/12

Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss

Phase: N/A Priority: Normal
NCT ID: NCT01325350 Org: User:
Start: 06/30/11 End: 09/30/12 Due: 09/30/13

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT00856414 Org: User:
Start: 03/31/09 End: 04/30/09 Due: 04/30/10